News

Latest News:

mc2_news-image-icon-07

MC2 Biotek successfully completes plaque psoriasis study

POSTED: May 1, 2015

MC2 Biotek has received positive results from a plaque psoriasis study comparing MC2-01 PAD™ Cream (fixed dose combination of Betamethasone dipropionate/calcipotriene) to vehicle, monads, Taclonex Ointment and Taclonex Topical Suspension.

Data ...

READ FULL ARTICLE >

Upcoming Events:

There are no upcoming events at the moment.

READ MORE >

© mc2 therapeutics 2020